TPW 8.01 High MELD Scores Are Not a Contraindication to Living Donor Liver Transplantation (LDLT): Acceptable Survival Outcomes in MELD >40 versus ≤40 LDLT Recipients
British Journal of Surgery · 05.08.2026 · 113 (Supplement_8)
DOI: 10.1093/bjs/znag087.390 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 05.08.2026. Verfasst von Selvakumar Naganathan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Patients with Model for End-Stage Liver Disease (MELD) scores >40 face exceptionally high waitlist mortality. Living-donor-liver-transplantation (LDLT) for this critically ill cohort remains contentious due to concerns regarding perioperative-risk and suboptimal outcomes.
Objectives
To determine whether LDLT achieves equivalent survival in MELD >40 patients compared to lower-severity recipients and to characterize the clinical risk-benefit profile.
Methods
Retrospective analysis of prospectively maintained data from a high-volume center encompassed 2,600 adult LDLT procedures (2010-2021). 74 MELD >40 recipients were compared against 2,015 MELD ≤40 recipients. Propensity score matching (1:3 ratio, 0.2 SD caliper) balanced 16 baseline covariates including demographics, disease severity, comorbidities, and transplant factors, achieving standardized mean differences <0.1. Primary outcomes were patient and allograft survival, analyzed via Kaplan-Meier estimation and stratified Cox regression. Secondary outcomes assessed perioperative complications, rejection episodes, and biochemical recovery through postoperative day 10.
Results
MELD >40 recipients demonstrated excellent outcomes. One-year survival reached 85.4% versus 87.5% for MELD ≤40 (HR 0.94, 95% CI 0.45-1.95, P=0.87), with five-year survival of 70.8% versus 68.2% (HR 0.98, P=0.95). Propensity-matched analysis revealed no significant differences: one-year survival 91.7% versus 88.9% (P=0.74), five-year graft survival 66.7% versus 64.8% (P=0.88). High-MELD recipients achieved 91% median bilirubin reduction (24.3 to 2.1 mg/dL) by day 10. Although requiring more perioperative dialysis (25.0% versus 10.8%, P=0.04), rejection rates (12.5% versus 14.5%, P=0.80) remained comparable.
Conclusions
LDLT delivers exceptional long-term survival for MELD >40 patients, with outcomes equivalent to lower-risk recipients, challenging existing paradigms and supporting LDLT as safe, effective intervention at experienced centers.
Zitieren
APA
Naganathan, S., Sharma, H., & Gupta, S. (2026). TPW 8.01 High MELD Scores Are Not a Contraindication to Living Donor Liver Transplantation (LDLT): Acceptable Survival Outcomes in MELD >40 versus ≤40 LDLT Recipients. British Journal of Surgery, 113(Supplement_8). https://doi.org/10.1093/bjs/znag087.390
Vancouver
Naganathan S, Sharma H, Gupta S. TPW 8.01 High MELD Scores Are Not a Contraindication to Living Donor Liver Transplantation (LDLT): Acceptable Survival Outcomes in MELD >40 versus ≤40 LDLT Recipients. British Journal of Surgery. 2026;113(Supplement_8). doi:10.1093/bjs/znag087.390
BibTeX
@article{Naganathan2026,
author = {Naganathan, Selvakumar and Sharma, Hemant and Gupta, Subash},
title = {TPW 8.01 High MELD Scores Are Not a Contraindication to Living Donor Liver Transplantation (LDLT): Acceptable Survival Outcomes in MELD >40 versus ≤40 LDLT Recipients},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_8},
doi = {10.1093/bjs/znag087.390}
}
EUVIMED